ATE256668T1 - Polyhydroxyalkylpyrazine derivate,deren herstellung und diese enthaltende arzneimitteln - Google Patents

Polyhydroxyalkylpyrazine derivate,deren herstellung und diese enthaltende arzneimitteln

Info

Publication number
ATE256668T1
ATE256668T1 AT98939679T AT98939679T ATE256668T1 AT E256668 T1 ATE256668 T1 AT E256668T1 AT 98939679 T AT98939679 T AT 98939679T AT 98939679 T AT98939679 T AT 98939679T AT E256668 T1 ATE256668 T1 AT E256668T1
Authority
AT
Austria
Prior art keywords
substituents
chain
ch2or8
production
products containing
Prior art date
Application number
AT98939679T
Other languages
English (en)
Inventor
Herve Bouchard
Alain Commercon
Jean-Francois Peyronel
Corinne Terrier
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of ATE256668T1 publication Critical patent/ATE256668T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT98939679T 1997-07-18 1998-07-15 Polyhydroxyalkylpyrazine derivate,deren herstellung und diese enthaltende arzneimitteln ATE256668T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9709186A FR2766185B1 (fr) 1997-07-18 1997-07-18 Medicaments contenant en tant que principe actif au moins un derive substitue de polyhydroxylalkylpyrazines, les nouveaux derives polyhydroxylalkylpyrazines et leur preparation
PCT/FR1998/001545 WO1999003843A1 (fr) 1997-07-18 1998-07-15 Derives de polyhydroxyalkylpyrazines, leur preparation et medicaments les contenant

Publications (1)

Publication Number Publication Date
ATE256668T1 true ATE256668T1 (de) 2004-01-15

Family

ID=9509395

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98939679T ATE256668T1 (de) 1997-07-18 1998-07-15 Polyhydroxyalkylpyrazine derivate,deren herstellung und diese enthaltende arzneimitteln

Country Status (12)

Country Link
US (1) US6380197B1 (de)
EP (1) EP1001943B1 (de)
JP (1) JP4443035B2 (de)
AT (1) ATE256668T1 (de)
AU (1) AU8810598A (de)
DE (1) DE69820634T2 (de)
DK (1) DK1001943T3 (de)
ES (1) ES2209186T3 (de)
FR (1) FR2766185B1 (de)
PT (1) PT1001943E (de)
WO (1) WO1999003843A1 (de)
ZA (1) ZA986330B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2788274B1 (fr) * 1999-01-11 2001-02-09 Aventis Pharma Sa Nouveaux derives de polyhydroxypyrazines, leur preparation et les compositions pharmaceutiques qui les contiennent
JP2010511408A (ja) 2006-12-04 2010-04-15 ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ 癌をＣｐＧリッチＤＮＡおよびキュプレドキシンで治療するための組成物および方法
US8011596B2 (en) * 2008-02-13 2011-09-06 Hand Held Products, Inc. Machine readable 2D symbology printable on demand
KR20220051164A (ko) 2019-07-05 2022-04-26 아이오엠엑스 테라퓨틱스 아게 Igsf11 (vsig3)의 항체 결합 igc2 및 이의 용도
EP4175668A1 (de) 2020-07-06 2023-05-10 iOmx Therapeutics AG Igv von igsf11 (vsig3) bindende antikörper und verwendungen davon

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3443141B2 (ja) * 1993-10-05 2003-09-02 株式会社リコー 画像傾き検出方法及び表処理方法
FR2744365B1 (fr) 1996-02-06 1998-02-27 Inst Malgache Rech Appl Melanges isolables a partir de graines d'eugenia jambolana lamarck, leur preparation et l'utilisation de ces melanges et certains de leurs constituants comme medicaments

Also Published As

Publication number Publication date
DE69820634T2 (de) 2004-10-21
US6380197B1 (en) 2002-04-30
PT1001943E (pt) 2004-07-30
EP1001943A1 (de) 2000-05-24
FR2766185A1 (fr) 1999-01-22
JP2001510187A (ja) 2001-07-31
JP4443035B2 (ja) 2010-03-31
WO1999003843A1 (fr) 1999-01-28
ES2209186T3 (es) 2004-06-16
FR2766185B1 (fr) 2001-06-15
DE69820634D1 (de) 2004-01-29
AU8810598A (en) 1999-02-10
DK1001943T3 (da) 2004-03-29
EP1001943B1 (de) 2003-12-17
ZA986330B (en) 1999-02-08

Similar Documents

Publication Publication Date Title
ATE133165T1 (de) Aza-macrozyklen und verfahren zu deren herstellung
FR2379553A1 (fr) Nouveaux photoinducteurs de polymerisation, compositions photopolymerisables les contenant et procede de photopolymerisation
DE69627042D1 (de) Isocumarinderivate und deren verwendung in medikamenten
FR2371436A1 (fr) Nouveaux derives de morpholine ou de piperidine utiles comme medicaments et comme fongicides
FR2403340A1 (fr) Derives imidazoliques utiles comme medicaments
ATE99315T1 (de) Platin(ii)-komplexe, verfahren zu ihrer herstellung und anwendung als antitumormittel.
FR2416888A1 (fr) Nouveaux derives de phenyl-piperazine utiles comme medicaments
DK0534445T3 (da) Fremgangsmåde til fremstilling af et lægemiddel til oral eller topisk administrering ved behandling af Leishmaniasis
FR2370028A1 (fr) Hydroxylamines alkylees, leur procede de preparation et leur emploi comme medicaments
FR2404626A1 (fr) Nouveaux derives a-halogenomethyles de l'acide g-aminobutyrique utiles comme medicaments et procedes de leur preparation
ATE256668T1 (de) Polyhydroxyalkylpyrazine derivate,deren herstellung und diese enthaltende arzneimitteln
FR2400008A1 (fr) Agents anti-hypertensifs
ATE6646T1 (de) Insektizide mittel und piperidinderivat.
FR2361346A1 (fr) Dipeptides utiles comme medicaments
DE69818679D1 (de) Pyrazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
FR2361361A1 (fr) Nouveaux derives du cyclopentane et medicaments contenant ces substances
DE68900516D1 (de) Therapeutische mittel zur behandlung von magengeschwueren.
FR2378741A1 (fr) Acides garyl goxo isovaleriques doues de proprietes antiphlogistiques et antalgiques
FR2359154A1 (fr) Derives peptidiques utiles comme medicaments et procede pour leur preparation
FR2713644B1 (fr) Nouveaux analogues de l'éburnane, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
ATE156798T1 (de) Penten-derivate, deren herstellung und verwendung
ATE55123T1 (de) Alkylcarbonsaeureamide von pyridinalkylaminen, ihre herstellung und ihre verwendung als arzneimittel.
ES473834A1 (es) Procedimiento de preparacion de nuevos compuestos indolicos.
EP0551844A3 (de)
FR2376139A1 (fr) Nouveaux derives d'isoquinoleine-acetamide utiles comme medicaments

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties